BMO Capital Markets upgraded shares of Extendicare (TSE:EXE – Free Report) to a hold rating in a report released on Tuesday,Zacks.com reports.
EXE has been the topic of several other reports. TD Securities lifted their target price on Extendicare from C$9.50 to C$10.50 and gave the company a “hold” rating in a research report on Thursday, November 14th. Royal Bank of Canada boosted their price objective on Extendicare from C$9.50 to C$11.00 and gave the company a “sector perform” rating in a research note on Thursday, November 28th.
Get Our Latest Stock Analysis on Extendicare
Extendicare Trading Down 0.2 %
Extendicare (TSE:EXE – Get Free Report) last announced its earnings results on Tuesday, November 12th. The company reported C$0.19 earnings per share (EPS) for the quarter. Extendicare had a net margin of 4.28% and a return on equity of 60.00%. During the same quarter last year, the business earned $0.13 earnings per share. Analysts expect that Extendicare will post 0.6134729 EPS for the current year.
Extendicare Announces Dividend
The firm also recently declared a monthly dividend, which will be paid on Friday, February 14th. Shareholders of record on Friday, February 14th will be issued a dividend of $0.04 per share. The ex-dividend date is Friday, January 31st. This represents a $0.48 dividend on an annualized basis and a yield of 4.64%. Extendicare’s dividend payout ratio is presently 70.59%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
See Also
- Five stocks we like better than Extendicare
- Why Are These Companies Considered Blue Chips?
- Arista Networks’ Stock Plunge: Buying Opportunity for Investors?
- 3 REITs to Buy and Hold for the Long Term
- As China Tightens Rare Earth Exports, These 3 Stocks Are in Focus
- Stock Dividend Cuts Happen Are You Ready?
- Rebuilding the Empire: Can Dollar General Rally in 2025?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.